We are live on ! Find out more
CLOV icon

Clover Health Investments

175 hedge funds and large institutions have $117M invested in Clover Health Investments in 2022 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 44 increasing their positions, 49 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

123% more call options, than puts

Call options by funds: $4.43M | Put options by funds: $1.99M

7% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 27

0.66% more ownership

Funds ownership: 32.19%32.86% (+0.66%)

0% more funds holding

Funds holding: 175175 (0)

10% less repeat investments, than reductions

Existing positions increased: 44 | Existing positions reduced: 49

33% less funds holding in top 10

Funds holding in top 10: 32 (-1)

44% less capital invested

Capital invested by funds: $210M → $117M (-$92.7M)

Holders
175
Holders Change
Holders Change %
0%
% of All Funds
2.81%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
29
Increased
44
Reduced
49
Closed
27
Calls
$4.43M
Puts
$1.99M
Net Calls
+$2.44M
Net Calls Change
-$607K
Name Holding Trade Value Shares
Change
Change in
Stake
Legal & General Group
51
Legal & General Group
United Kingdom
$142K
Manulife (Manufacturers Life Insurance)
52
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$141K +$11.5K +8,637 +6%
VOYA Investment Management
53
VOYA Investment Management
Georgia
$140K
MIM
54
MetLife Investment Management
New Jersey
$138K -$77.4K -58,013 -28%
MP
55
MSD Partners
New York
$137K
TSS
56
Two Sigma Securities
New York
$132K +$98.8K +74,058 +108%
Group One Trading
57
Group One Trading
Illinois
$119K -$367K -275,250 -68%
AGM
58
Alpine Global Management
New York
$115K +$143K +107,194 +639%
ASRS
59
Arizona State Retirement System
Arizona
$85.4K +$5.87K +4,398 +5%
William Blair & Company
60
William Blair & Company
Illinois
$85.3K -$11.8K -8,850 -9%
Royal Bank of Canada
61
Royal Bank of Canada
Ontario, Canada
$71K +$78K +58,440 +334%
Truist Financial
62
Truist Financial
North Carolina
$70.1K -$68K -50,925 -40%
GCP
63
GSA Capital Partners
United Kingdom
$69K +$99.6K +74,651 New
EGM
64
Engineers Gate Manager
New York
$65.6K +$77.8K +58,337 +475%
SAM
65
SignalPoint Asset Management
Missouri
$65K
AI
66
Atom Investors
Texas
$61.8K +$88.7K +66,482 New
Janus Henderson Group
67
Janus Henderson Group
United Kingdom
$59.2K -$85.2K -63,839 -50%
HSA
68
HBK Sorce Advisory
Pennsylvania
$58K +$40.9K +30,667 +95%
AB
69
Amalgamated Bank
New York
$57K
PLU
70
Performa Ltd (US)
South Carolina
$53.9K +$25.4K +19,000 +49%
EPM
71
Equitec Proprietary Markets
Illinois
$52.6K -$60.4K -45,300 -44%
Russell Investments Group
72
Russell Investments Group
United Kingdom
$50.9K -$73.4K -55,000 -50%
HSBC Holdings
73
HSBC Holdings
United Kingdom
$50.8K
Baird Financial Group
74
Baird Financial Group
Wisconsin
$50K -$16 -12 -0%
ProShare Advisors
75
ProShare Advisors
Maryland
$46.2K +$9.51K +7,124 +17%

CLOV Hedge Fund Activity: Q4 2022 in Review

175 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Clover Health Investments (CLOV) for Q4 2022, worth a combined $117M — down 44% from $210M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new CLOV positions and 27 closed out — a net gain of 2 holders — while 44 added to existing stakes and 49 trimmed.

The largest buyer was Jane Street, adding an estimated $3.24M. The largest seller was D.E. Shaw & Co, cutting an estimated $2.56M.

  • 175 institutional investors held Clover Health Investments (CLOV) as of Q4 2022, unchanged from Q3 2022.
  • Funds reported $117M of Clover Health Investments stock for Q4 2022, down 44% quarter-over-quarter.
  • 29 funds opened new Clover Health Investments positions in Q4 2022 and 27 closed out, a net change of +2 holders.
  • The largest Clover Health Investments buyer in Q4 2022 was Jane Street, an estimated $3.24M added.
  • The largest Clover Health Investments seller in Q4 2022 was D.E. Shaw & Co, an estimated $2.56M sold.

Based on aggregated 13F filings for Q4 2022.